Impact of Immunosuppression on the Metagenomic Composition of the Intestinal Microbiome: a Systems Biology Approach to Post-Transplant Diabetes

Overview

Journal Sci Rep

Specialty Science

Date 2017 Sep 2

PMID 28860611

Citations 34

Authors

M Bhat

E Pasini

J Copeland

M Angeli

S Husain

D Kumar

E Renner

A Teterina

J Allard

D S Guttman

A Humar

Affiliations

Soon will be listed here.

Abstract

Solid organ transplantation (SOT) outcomes have continued to improve, although long-term use of immunosuppressants can lead to complications such as diabetes, compromising post-transplant outcomes. In this study, we have characterized the intestinal microbiome (IM) composition at the metagenomic level in the context of hyperglycemia induced by immunosuppressants. Sprague-Dawley rats were subjected to doses of tacrolimus and sirolimus that reliably induce hyperglycemia and an insulin-resistant state. Subsequent exposure to probiotics resulted in reversal of hyperglycemia. 16S rRNA and metagenomic sequencing of stool were done to identify the bacterial genes and pathways enriched in immunosuppression. Bacterial diversity was significantly decreased in sirolimus-treated rats, with 9 taxa significantly less present in both immunosuppression groups: Roseburia, Oscillospira, Mollicutes, Rothia, Micrococcaceae, Actinomycetales and Staphylococcus. Following probiotics, these changes were reversed to baseline. At the metagenomic level, the balance of metabolism was shifted towards the catabolic side with an increase of genes involved in sucrose degradation, similar to diabetes. Conversely, the control rats had greater abundance of anabolic processes and genes involved in starch degradation. Immunosuppression leads to a more catabolic microbial profile, which may influence development of diabetes after SOT. Modulation of the microbiome with probiotics may help in minimizing adverse long-term effects of immunosuppression.

Citing Articles

The effects of restraint stress and orthodontic tooth movements on the intestinal epithelial structure and metabolic function in rats.

Cheng Y, Li Y, Fan Z, Wang N, Wang M, Li Y PLoS One. 2025; 20(2):e0319779.

PMID: 40014578 PMC: 11867309. DOI: 10.1371/journal.pone.0319779.

Tacrolimus and diabetic rodent models.

Qian M, Guan M, Wang L, Hu N Pharmacol Rep. 2025; .

PMID: 39836342 DOI: 10.1007/s43440-024-00693-3.

Gut microbiota modulation in cardiac cell therapy with immunosuppression in a nonhuman primate ischemia/reperfusion model.

Chen H, Cheng Y, Hsieh M, Lin P, Wissel E, Steward T NPJ Regen Med. 2025; 10(1):2.

PMID: 39809790 PMC: 11733301. DOI: 10.1038/s41536-025-00390-6.

A Case Series Report on the Effect of Tofacitinib on Joint Inflammation and Gut Microbiota Composition in Psoriatic Arthritis Patients Naive to Biologic Agents.

Picchianti Diamanti A, Panebianco C, Di Gioia V, Bellofatto I, Salemi S, Di Rosa R Microorganisms. 2025; 12(12.

PMID: 39770590 PMC: 11676042. DOI: 10.3390/microorganisms12122387.

Gut Microbial Dysbiosis and Implications in Solid Organ Transplantation.

Medina C, Aykut B Biomedicines. 2025; 12(12.

PMID: 39767699 PMC: 11673786. DOI: 10.3390/biomedicines12122792.

References

Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett W . Metagenomic biomarker discovery and explanation. Genome Biol. 2011; 12(6):R60. PMC: 3218848. DOI: 10.1186/gb-2011-12-6-r60. View

Segata N, Waldron L, Ballarini A, Narasimhan V, Jousson O, Huttenhower C . Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods. 2012; 9(8):811-4. PMC: 3443552. DOI: 10.1038/nmeth.2066. View

Ellekilde M, Selfjord E, Larsen C, Jakesevic M, Rune I, Tranberg B . Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice. Sci Rep. 2014; 4:5922. PMC: 4118149. DOI: 10.1038/srep05922. View

Barreto F, Simao A, Morimoto H, Lozovoy M, Dichi I, Miglioranza L . Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition. 2014; 30(7-8):939-42. DOI: 10.1016/j.nut.2013.12.004. View

Parks D, Tyson G, Hugenholtz P, Beiko R . STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014; 30(21):3123-4. PMC: 4609014. DOI: 10.1093/bioinformatics/btu494. View

Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F . A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490(7418):55-60. DOI: 10.1038/nature11450. View

Lewis A, McCourt H, Ennis C, Bell P, Courtney C, McKinley M . Comparison of 5% versus 15% sucrose intakes as part of a eucaloric diet in overweight and obese subjects: effects on insulin sensitivity, glucose metabolism, vascular compliance, body composition and lipid profile. A randomised controlled trial. Metabolism. 2013; 62(5):694-702. DOI: 10.1016/j.metabol.2012.11.008. View

Langmead B, Salzberg S . Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357-9. PMC: 3322381. DOI: 10.1038/nmeth.1923. View

Hackman K, Bailey M, Snell G, Bach L . Diabetes is a major risk factor for mortality after lung transplantation. Am J Transplant. 2014; 14(2):438-45. DOI: 10.1111/ajt.12561. View

10.

Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G . Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500(7464):541-6. DOI: 10.1038/nature12506. View

11.

Shivaswamy V, McClure M, Passer J, Frahm C, Ochsner L, Erickson J . Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal sprague-dawley rats. Endocrine. 2010; 37(3):489-96. DOI: 10.1007/s12020-010-9332-6. View

12.

Edgar R . UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013; 10(10):996-8. DOI: 10.1038/nmeth.2604. View

13.

Lee J, Muthukumar T, Dadhania D, Toussaint N, Ling L, Pamer E . Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014; 98(7):697-705. PMC: 4189837. DOI: 10.1097/TP.0000000000000370. View

14.

Ali I, Adberrahim E, Ben Abdelghani K, Barbouch S, Mchirgui N, Khiari K . Incidence and risk factors for post-renal transplant diabetes mellitus. Transplant Proc. 2011; 43(2):568-71. DOI: 10.1016/j.transproceed.2011.01.032. View

15.

Vrieze A, van Nood E, Holleman F, Salojarvi J, Kootte R, Bartelsman J . Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143(4):913-6.e7. DOI: 10.1053/j.gastro.2012.06.031. View

16.

Jindal R, Sidner R, Milgrom M . Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf. 1997; 16(4):242-57. DOI: 10.2165/00002018-199716040-00002. View

17.

Turnbaugh P, Ley R, Mahowald M, Magrini V, Mardis E, Gordon J . An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444(7122):1027-31. DOI: 10.1038/nature05414. View

18.

Vazquez-Baeza Y, Pirrung M, Gonzalez A, Knight R . EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience. 2013; 2(1):16. PMC: 4076506. DOI: 10.1186/2047-217X-2-16. View

19.

Tourret J, Willing B, Dion S, MacPherson J, Denamur E, Finlay B . Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli. Transplantation. 2016; 101(1):74-82. DOI: 10.1097/TP.0000000000001492. View

20.

Xu C, Niu Y, Liu X, Teng Y, Li C, Wang H . Tacrolimus reversibly reduces insulin secretion, induces insulin resistance, and causes islet cell damage in rats. Int J Clin Pharmacol Ther. 2014; 52(7):620-7. DOI: 10.5414/CP202090. View